119 related articles for article (PubMed ID: 35089073)
1. Noninvasive Detection of Esophageal Cancer by the Combination of mSEPT9 and SNCG.
Zhang L; Yang X; Tian Y; Yu Q; Zhou D; Wu Z; Zhao X
Genet Test Mol Biomarkers; 2022 Jan; 26(1):8-16. PubMed ID: 35089073
[No Abstract] [Full Text] [Related]
2. Opportunistic screening and survival prediction of digestive cancers by the combination of blood
Song L; Chen Y; Gong Y; Wan J; Guo S; Liu H; Li Y; Zeng Z; Lu Y
Ther Adv Med Oncol; 2020; 12():1758835920962966. PubMed ID: 33403008
[TBL] [Abstract][Full Text] [Related]
3. Distinct Performance of Methylated
Tang H; Ma X; Zhou L; Li W; Shu Y; Xu H; Li J; Wang F; Sun F; Duan Y
Genet Test Mol Biomarkers; 2022 Apr; 26(4):239-248. PubMed ID: 35481971
[No Abstract] [Full Text] [Related]
4. A combination of methylation and protein markers is capable of detecting gastric cancer detection by combined markers.
Xu J; Song J; Wang T; Zhu W; Zuo L; Wu J; Guo J; Yang X
Epigenomics; 2021 Oct; 13(19):1557-1570. PubMed ID: 34632818
[TBL] [Abstract][Full Text] [Related]
5. Synuclein-gamma predicts poor clinical outcome in esophageal cancer patients.
Tastekin D; Kargin S; Karabulut M; Yaldız N; Tambas M; Gurdal N; Tatli AM; Arslan D; Gok AF; Aykan F
Tumour Biol; 2014 Dec; 35(12):11871-7. PubMed ID: 25142230
[TBL] [Abstract][Full Text] [Related]
6. Combined phenotype of 4 markers improves prognostic value of patients with colon cancer.
Liu C; Qu L; Dong B; Xing X; Ren T; Zeng Y; Jiang B; Meng L; Wu J; Shou C
Am J Med Sci; 2012 Apr; 343(4):295-302. PubMed ID: 22261620
[TBL] [Abstract][Full Text] [Related]
7. [Value of plasma SEPTIN9 methylation detection for diagnosis and predicting radiosensitivity of esophageal carcinoma].
Sun Q; Liu J; Fan X; Zhou Y; Wang X; Cui Z
Nan Fang Yi Ke Da Xue Xue Bao; 2021 Aug; 41(8):1214-1219. PubMed ID: 34549713
[TBL] [Abstract][Full Text] [Related]
8. Gamma-synuclein is a novel prognostic marker that promotes tumor cell migration in biliary tract carcinoma.
Takemura Y; Ojima H; Oshima G; Shinoda M; Hasegawa Y; Kitago M; Yagi H; Abe Y; Hori S; Fujii-Nishimura Y; Kubota N; Masuda Y; Hibi T; Sakamoto M; Kitagawa Y
Cancer Med; 2021 Aug; 10(16):5599-5613. PubMed ID: 34245137
[TBL] [Abstract][Full Text] [Related]
9.
Li B; Huang H; Huang R; Zhang W; Zhou G; Wu Z; Lv C; Han X; Jiang L; Li Y; Li B; Zhang Z
Dis Markers; 2020; 2020():6289063. PubMed ID: 33178361
[TBL] [Abstract][Full Text] [Related]
10. Synuclein-γ (SNCG) protein expression is associated with poor outcome in endometrial adenocarcinoma.
Mhawech-Fauceglia P; Wang D; Syriac S; Godoy H; Dupont N; Liu S; Odunsi K
Gynecol Oncol; 2012 Jan; 124(1):148-52. PubMed ID: 22015044
[TBL] [Abstract][Full Text] [Related]
11. Synuclein gamma predicts poor clinical outcome in colon cancer with normal levels of carcinoembryonic antigen.
Liu C; Dong B; Lu A; Qu L; Xing X; Meng L; Wu J; Eric Shi Y; Shou C
BMC Cancer; 2010 Jul; 10():359. PubMed ID: 20604972
[TBL] [Abstract][Full Text] [Related]
12. Assessment of serum synuclein-γ and squamous cell carcinoma antigen as diagnostic biomarkers in patients with oral squamous cell carcinoma and oral potentially malignant disorders.
Chen L; Luo T; Yang J; Wang K; Liu S; Wei Y; Liu H; Xu J; Zheng J; Zeng Y
J Oral Pathol Med; 2021 Feb; 50(2):165-174. PubMed ID: 33064859
[TBL] [Abstract][Full Text] [Related]
13. Alternative splicing of synuclein gamma in endometrial cancer: identification of a novel isoform.
Schaal K; Hirschfeld M; Bronsert P; Füllgraf H; Jäger M; Herde B; Nöthling C; Mayer S; Erbes T; Stickeler E
Oncotarget; 2015 Sep; 6(26):22553-63. PubMed ID: 26265438
[TBL] [Abstract][Full Text] [Related]
14. Urine gamma-synuclein as a biomarker for the diagnosis of bladder cancer.
Liu C; Shi B; Hao C; Wang Q; Lv Q; Xing N; Shou J; Qu L; Gao Y; Qin C; Zhao J; Shou C
Oncotarget; 2016 Jul; 7(28):43432-43441. PubMed ID: 27223068
[TBL] [Abstract][Full Text] [Related]
15. Performance of circulating methylated Septin9 gene DNA in diagnosis and recurrence monitoring of colorectal cancer in Western China.
Gao JJ; Wang YW; Li Y; Wang ZL; Feng A; Li N; Hui LY
Clin Chim Acta; 2022 Dec; 537():118-126. PubMed ID: 36330944
[TBL] [Abstract][Full Text] [Related]
16. Methylated Septin9 has moderate diagnostic value in colorectal cancer detection in Chinese population: a multicenter study.
Lu DC; Zhang QF; Li L; Luo XK; Liang B; Lu YH; Hu BL; Jiang HX
BMC Gastroenterol; 2022 May; 22(1):232. PubMed ID: 35546391
[TBL] [Abstract][Full Text] [Related]
17. Expression of neuronal protein synuclein gamma gene as a novel marker for breast cancer prognosis.
Wu K; Quan Z; Weng Z; Li F; Zhang Y; Yao X; Chen Y; Budman D; Goldberg ID; Shi YE
Breast Cancer Res Treat; 2007 Mar; 101(3):259-67. PubMed ID: 16821081
[TBL] [Abstract][Full Text] [Related]
18. Promoter methylation in cytology specimens as an early detection marker for esophageal squamous dysplasia and early esophageal squamous cell carcinoma.
Adams L; Roth MJ; Abnet CC; Dawsey SP; Qiao YL; Wang GQ; Wei WQ; Lu N; Dawsey SM; Woodson K
Cancer Prev Res (Phila); 2008 Oct; 1(5):357-61. PubMed ID: 19137073
[TBL] [Abstract][Full Text] [Related]
19. Expression of synuclein gamma indicates poor prognosis of triple-negative breast cancer.
Wu K; Huang S; Zhu M; Lu Y; Chen J; Wang Y; Lin Q; Shen W; Zhang S; Zhu J; Shi YE; Weng Z
Med Oncol; 2013; 30(3):612. PubMed ID: 23696021
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of synuclein-γ predicts lack of benefit from radiotherapy for breast cancer patients.
Min L; Zhang C; Ma R; Li X; Yuan H; Li Y; Chen R; Liu C; Guo J; Qu L; Shou C
BMC Cancer; 2016 Sep; 16(1):717. PubMed ID: 27595752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]